MUNICH, Oct. 17, 2019 /PRNewswire/ — inCare, the digital health company offering digital medicine solutions, announced that it has rolled out its digital platform throughout Europe.
inCare’s Digital Platform is seeing adoption with partners in European countries including Austria, Hungary, Poland, Bulgaria, Netherlands, Belgium and Germany. The unique platform captures human data, feedback and biometrics from the patient for application integration and analysis.
The company is partnering with multiple wearable sensors enabling capturing digital biomarkers as part of clinical studies.
Healthcare applications using the inCare Digital Platform are combining mobile applications, wearable and artificial intelligence technologies in a digital medicine and therapy platform for personalization, clinical trials and adherence improvement in acute and chronic diseases and including:
“inCare’s digital platform is now offering throughout Europe deeper insights about patient health patterns and medication treatment effectiveness, leading to more informed healthcare decisions and better outcomes for everyone involved,” said Dr. Roman Schenk, Chairman of inCare, in a statement. “inCare is working to expand its partnerships with players in biopharma, diagnostics and clinical research.”
About InCare
inCare is combining mobile applications, wearable and artificial intelligence technologies in a digital medicine and therapy platform for personalization, clinical trials and adherence improvement.
We are transforming care by extending digital health beyond activity monitoring and offering deeper insights about patient health patterns, data and medication treatment effectiveness, leading to more informed healthcare decisions and better outcomes for everyone involved.
Media Contact:
Related Images
incare-digital-platform.png
inCare Digital Platform
View original content to download multimedia:http://www.prnewswire.com/news-releases/incare-digital-platform-rolled-out-in-europe-300940760.html
SOURCE inCare
PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a…
Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed…
PITTSBURGH & SACRAMENTO, Calif.--(BUSINESS WIRE)--Today, Abridge and Sutter Health announced they will make Abridge’s generative…
Presentations Will Feature Studies Evaluating TENEO™ Excimer Laser Platform, MIEBO® (Perfluorohexyloctane Ophthalmic Solution) and enVista®…
Blackstone Life Sciences to invest up to $750 million to support innovative mRNA technologyNEW YORK--(BUSINESS…
Phase 1a study of first hormone-free male pill completes enrollmentDURHAM, NC / ACCESSWIRE / March…